Display Options:
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Glioma; Antiphospholipid Syndrome; Aortic Valve Stenosis; Hepatitis C; Hepatitis C, Chronic; Nephritis, Hereditary; Prostatic Neoplasms, Castration-Resistant; Erectile Dysfunction; Hypercholesterolemia; Lipid Metabolism Disorders; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Kidney Diseases; Otitis Media; Communicable Diseases; Graft vs Host Disease; Abscess; Cholecystitis, Acute; Diabetic Foot; Enterobacteriaceae Infections; Hematologic Neoplasms; Infections; Influenza, Human; Pancreatic Neoplasms; Pneumonia; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Pseudomonas Infections; Pyelonephritis; Sepsis; Severe Acute Respiratory Syndrome; Shock, Septic; Urinary Tract Infections; Bacterial Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Vitamin D receptor agonist
ROUTE OF ADMINISTRATION: TOPICAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Scleroderma, Localized; Vitiligo; Acne Vulgaris; Dermatitis, Atopic; Eczema; Radiodermatitis; Skin Diseases; Psoriasis
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Serotonin 4 (5-HT4) receptor agonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Digestive System Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Amphetamine-Related Disorders; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Alzheimer Disease; Aortic Aneurysm, Abdominal; Breast Neoplasms; Neoplasms; Cardiomyopathy, Dilated; Diabetes Mellitus, Type 2; Hypertension; Marfan Syndrome; Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Hyperopia; Multiple Sclerosis; Uterine Cervical Neoplasms; Acidosis, Lactic; Brain Concussion; Chronic Pain; Heart Failure; Myocardial Infarction; Myopia; Psoriasis; Refractive Errors; Diabetic Neuropathies; Hematologic Diseases; Keratoconus; Anemia; Anemia, Iron-Deficiency; Eye Diseases; Folic Acid Deficiency; Kidney Failure, Chronic
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium-(potassium)-chloride cotransporter 2 inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Diabetes Mellitus, Type 2; Pre-Eclampsia; Cardiovascular Diseases; Heart Failure; Hypertension; Myocardial Infarction; Stroke
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Serotonin 3a (5-HT3a) receptor antagonist
ROUTE OF ADMINISTRATION: SUBCUTANEOUS; TRANSDERMAL
STATUS: Approved
THERAPEUTIC AREA: CANCER
THERAPEUTIC INDICATION: Gastroparesis; Glioma; Leukemia, Mast-Cell; Lymphoma; Pruritus; Uterine Cervical Neoplasms; Vomiting; Nausea; Neoplasms; Postoperative Nausea and Vomiting
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Eye Manifestations; Nasal Obstruction
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Diagnostic agent
ROUTE OF ADMINISTRATION: INJECTION
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Voltage-gated calcium channel modulator
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: IMMUNE SYSTEM; NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER; PEDIATRICS
THERAPEUTIC INDICATION: Premature Birth; Psychotic Disorders; Abortion, Spontaneous; Anemia, Sickle Cell; Breast Neoplasms; HIV Infections; Hyperemesis Gravidarum; Intervertebral Disc Displacement; Low Back Pain; Marijuana Abuse; Mucositis; Multiple Sclerosis; Neoplasms; Opioid-Related Disorders; Paget Disease, Extramammary; Postoperative Complications; Prostatic Neoplasms, Castration-Resistant; Rotator Cuff Injuries; Sleep Wake Disorders; Substance Withdrawal Syndrome; Substance-Related Disorders; Tinnitus; Tobacco Use Disorder; Urinary Bladder Neoplasms; Wounds and Injuries; Alcohol Drinking; Alcoholism; Anxiety; Azoospermia; Brain Injuries; Carpal Tunnel Syndrome; Chronic Pain; Delirium; Dementia; Depressive Disorder; Diabetic Neuropathies; Dyspepsia; Epilepsies, Partial; Fibromyalgia; Head and Neck Neoplasms; Herpes Zoster; Hot Flashes; Intervertebral Disc Degeneration; Liver Cirrhosis; Lung Diseases; Neuralgia; Oropharyngeal Neoplasms; Pain; Pelvic Organ Prolapse; Postoperative Nausea and Vomiting; Pruritus; Schizophrenia; Scoliosis; Sleep Initiation and Maintenance Disorders; Tremor; Vomiting; Epilepsy; Neuralgia, Postherpetic; Restless Legs Syndrome; Seizures
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Heart Failure; Kidney Failure, Chronic
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: DNA inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Central Nervous System Neoplasms; Graft vs Host Disease; Multiple Myeloma; Myeloproliferative Disorders; Blast Crisis; Cholangitis, Sclerosing; Histiocytosis; Histiocytosis, Langerhans-Cell; Leukemia, Biphenotypic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Mantle-Cell; Mastocytosis, Systemic; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Multiple Sclerosis, Relapsing-Remitting; Anemia; Immune System Diseases; Leukemia, Hairy Cell; Multiple Sclerosis; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Opioid-Related Disorders; Substance-Related Disorders
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Dopamine D2 receptor antagonist
ROUTE OF ADMINISTRATION: INTRAMUSCULAR; ORAL; SUBCUTANEOUS
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Dyskinesia, Drug-Induced; Huntington Disease; Lecithin Cholesterol Acyltransferase Deficiency; Schizotypal Personality Disorder; Amphetamine-Related Disorders; Child Development Disorders, Pervasive; Cocaine-Related Disorders; Obsessive-Compulsive Disorder; Stress Disorders, Post-Traumatic; Tourette Syndrome; Alzheimer Disease; Anxiety; Asperger Syndrome; Attention Deficit and Disruptive Behavior Disorders; Conduct Disorder; Dementia; Dementia, Vascular; Depressive Disorder; Depressive Disorder, Major; Developmental Disabilities; Intellectual Disability; Neurodevelopmental Disorders; Rett Syndrome; Aggression; Autistic Disorder; Bipolar Disorder; Psychotic Disorders; Schizophrenia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Depressive Disorder, Major; Depressive Disorder
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Peroxisome proliferator-activated receptor alpha agonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR; DIABETES DRUGS & ENDOCRINOLOGY; OTHER
THERAPEUTIC INDICATION: Cholangitis, Sclerosing; Alcoholism; Burns; Diabetic Nephropathies; HIV Infections; Huntington Disease; Metabolic Syndrome; Multiple Myeloma; Non-alcoholic Fatty Liver Disease; Obesity; Atherosclerosis; Coronary Disease; Diabetic Retinopathy; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemias; Hypertension; Hypertriglyceridemia; Lipid Metabolism Disorders; Lipodystrophy; Liver Cirrhosis, Biliary; Metabolic Diseases; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Dyslipidemias; Hypercholesterolemia; Hypothyroidism
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glutamate [NMDA] receptor antagonist
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Bipolar Disorder; Anemia; Epilepsy; Seizures
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: CARDIOVASCULAR
THERAPEUTIC INDICATION: Bronchopulmonary Dysplasia
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Eye Manifestations
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Cardiovascular Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Sodium channel alpha subunit blocker
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: NEUROLOGY DRUGS & NERVOUS SYSTEM; OTHER
THERAPEUTIC INDICATION: HIV Infections; Lecithin Cholesterol Acyltransferase Deficiency; Mental Disorders; Alcoholism; Cocaine-Related Disorders; Cognitive Dysfunction; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Neuralgia, Postherpetic; Neurofibromatosis 1; Opioid-Related Disorders; Substance-Related Disorders; Anxiety; Dementia; Epilepsy, Absence; Feeding and Eating Disorders; Mood Disorders; Obesity; Pain; Peripheral Nervous System Diseases; Schizophrenia; Bipolar Disorder; Depressive Disorder; Epilepsies, Partial; Epilepsy; Epilepsy, Tonic-Clonic; Lennox Gastaut Syndrome; Seizures
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Fatty Liver; Cystic Fibrosis; HIV Infections; Cystinosis; Influenza, Human; Pneumonia; Severe Acute Respiratory Syndrome; Eye Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Neoplasms; Panic Disorder; Anxiety; Anxiety Disorders; Anxiety, Separation; Autistic Disorder; Dementia; Obsessive-Compulsive Disorder; Phobia, Social; Schizophrenia; Severe Acute Respiratory Syndrome; Depressive Disorder
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Glucocorticoid receptor agonist
ROUTE OF ADMINISTRATION: INHALATION; NASAL; ORAL; RECTAL
STATUS: Approved
THERAPEUTIC AREA: GASTROINTESTINAL; OTHER; RESPIRATORY
THERAPEUTIC INDICATION: Cholangitis, Sclerosing; Aspergillosis, Allergic Bronchopulmonary; Breast Neoplasms; Bronchiolitis Obliterans; Diarrhea; Esophageal Stenosis; Glomerulonephritis, IGA; Hepatitis, Autoimmune; Hypersensitivity; Lung Neoplasms; Malnutrition; Melanoma; Multiple Myeloma; Nasal Polyps; Radiation Pneumonitis; Respiratory Distress Syndrome; Status Asthmaticus; Altitude Sickness; Bronchopulmonary Dysplasia; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Eosinophilic Esophagitis; Graft vs Host Disease; Liver Cirrhosis, Biliary; Proctitis; Proctocolitis; Respiratory Tract Diseases; Severe Acute Respiratory Syndrome; Sinusitis; Sleep Apnea, Obstructive; Snoring; Asthma; Bronchitis, Chronic; Colitis, Ulcerative; Crohn Disease; Emphysema; Lung Diseases, Obstructive; Nasal Obstruction; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Desmoplastic Small Round Cell Tumor; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Adenocarcinoma of Lung; Carcinoma, Large Cell; Diffuse Intrinsic Pontine Glioma; Fallopian Tube Neoplasms; Head and Neck Neoplasms; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Melanoma; Multiple Myeloma; Ovarian Neoplasms; Rhabdomyosarcoma; Sarcoma; Triple Negative Breast Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Lung Neoplasms; Lymphoma, Non-Hodgkin; Mesothelioma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Uterine Cervical Neoplasms; Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Diagnostic agent
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Alzheimer Disease; Arthritis, Rheumatoid; Carcinoma, Renal Cell; Gliosarcoma; Head and Neck Neoplasms; Hematologic Neoplasms; Melanoma; Mycosis Fungoides; Adenocarcinoma, Follicular; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Kidney Neoplasms; Lung Neoplasms; Lymphoma, Follicular; Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Sarcoma; Stomach Neoplasms; Thyroid Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; von Hippel-Lindau Disease; Lymphoma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Histamine H1 receptor antagonist
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Common Cold; Influenza, Human; Respiratory Tract Infections
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: FK506-binding protein 1A inhibitor
ROUTE OF ADMINISTRATION: INJECTION; ORAL; TOPICAL
STATUS: Approved
THERAPEUTIC AREA: DERMATOLOGY; DIABETES DRUGS & ENDOCRINOLOGY; OTHER; UROLOGY AND KIDNEY
THERAPEUTIC INDICATION: Alopecia; Aspergillosis; Blast Crisis; DiGeorge Syndrome; Hematologic Diseases; Hypercholesterolemia; Infections; Kidney Tubular Necrosis, Acute; Leukemia, Plasma Cell; Lymphedema; Lymphoma, T-Cell; Paget Disease, Extramammary; Peripheral Nerve Injuries; Respiratory Syncytial Virus Infections; Scleroderma, Localized; Vasculitis; Venous Thromboembolism; beta-Thalassemia; Amyotrophic Lateral Sclerosis; Anemia, Aplastic; Anemia, Diamond-Blackfan; Anemia, Sickle Cell; Asthma; Bone Marrow Failure Disorders; Burkitt Lymphoma; Chemical and Drug Induced Liver Injury; Colitis; Crohn Disease; Diabetes Mellitus; Edema; Encephalomyelitis; Epidermolysis Bullosa; Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental; Granuloma, Lethal Midline; Hematologic Neoplasms; Hepatitis C; Hepatitis C, Chronic; Hepatitis, Autoimmune; Histiocytosis, Langerhans-Cell; Hypertension, Pulmonary; Immunoblastic Lymphadenopathy; Kidney Neoplasms; Leukemia; Leukemia, Hairy Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Leukemia, Myelomonocytic, Juvenile; Leukemia-Lymphoma, Adult T-Cell; Lichen Planus, Oral; Liver Diseases; Liver Failure; Lung Diseases; Lupus Erythematosus, Cutaneous; Lymphoma; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Mantle-Cell; Lymphoma, T-Cell, Peripheral; Macular Degeneration; Multiple Myeloma; Multiple Sclerosis; Mycosis Fungoides; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Neoplasms; Nephrosis, Lipoid; Neuroblastoma; Polycythemia Vera; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Prostatic Neoplasms, Castration-Resistant; Purpura, Thrombocytopenic, Idiopathic; Red-Cell Aplasia, Pure; Reperfusion Injury; Sarcoma; Scleroderma, Systemic; Severe Combined Immunodeficiency; Sezary Syndrome; Shwachman-Diamond Syndrome; Thalassemia; Vulvar Lichen Sclerosus; Waldenstrom Macroglobulinemia; Wiskott-Aldrich Syndrome; Wounds and Injuries; Arthritis, Rheumatoid; Bronchiolitis Obliterans; Carcinoma, Hepatocellular; Colitis, Ulcerative; Conjunctivitis, Allergic; Dermatitis, Atopic; Dermatitis, Seborrheic; Diabetes Mellitus, Type 1; Glomerulonephritis, Membranous; Graft vs Host Disease; Heart Diseases; Hodgkin Disease; Infertility; Keratoconjunctivitis; Kidney Diseases; Lupus Nephritis; Lymphoma, Non-Hodgkin; Myasthenia Gravis; Myelodysplastic Syndromes; Nephrotic Syndrome; Pancreatitis; Psoriasis; Renal Insufficiency; Renal Insufficiency, Chronic; Severe Acute Respiratory Syndrome; Skin Neoplasms; Vitiligo; Eczema; Immune System Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: DIABETES DRUGS & ENDOCRINOLOGY; OTHER; PEDIATRICS
THERAPEUTIC INDICATION: Acidosis, Lactic; AIDS Dementia Complex; AIDS-Associated Nephropathy; Acquired Immunodeficiency Syndrome; HIV Infections; Virus Diseases
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Unknown
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Unknown
ROUTE OF ADMINISTRATION: Unknown
STATUS: Approved
THERAPEUTIC AREA: Unknown
THERAPEUTIC INDICATION: Wet Macular Degeneration; Glaucoma, Open-Angle; Ocular Hypertension; Glaucoma
MOLECULE TYPE: Small molecule
MECHANISMS OF ACTION: Serotonin transporter inhibitor
ROUTE OF ADMINISTRATION: ORAL
STATUS: Approved
THERAPEUTIC AREA: OTHER
THERAPEUTIC INDICATION: Panic Disorder; Severe Acute Respiratory Syndrome; Obsessive-Compulsive Disorder